MassMutual Private Wealth & Trust’s Supernus Pharmaceuticals SUPN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$13.6K Hold
292
﹤0.01% 1265
2026
Q1
$15.1K Sell
292
-40
-12% -$2.04K ﹤0.01% 1215
2025
Q4
$16.5K Buy
332
+36
+12% +$1.75K ﹤0.01% 1196
2025
Q3
$14.1K Hold
296
﹤0.01% 1256
2025
Q2
$9.33K Buy
296
+14
+5% +$449 ﹤0.01% 1389
2025
Q1
$9.24K Buy
282
+172
+156% +$6.09K ﹤0.01% 1336
2024
Q4
$3.98K Hold
110
﹤0.01% 1612
2024
Q3
$3.43K Buy
110
+9
+9% +$281 ﹤0.01% 1490
2024
Q2
$2.7K Sell
101
-219
-68% -$6.35K ﹤0.01% 1537
2024
Q1
$10.9K Hold
320
﹤0.01% 1018
2023
Q4
$9.26K Buy
320
+163
+104% +$4.32K ﹤0.01% 1049
2023
Q3
$4.33K Sell
157
-102
-39% -$3.1K ﹤0.01% 1295
2023
Q2
$7.79K Buy
259
+65
+34% +$2.27K ﹤0.01% 1053
2023
Q1
$7.03K Hold
194
﹤0.01% 1050
2022
Q4
$7K Hold
194
﹤0.01% 902
2022
Q3
$7K Buy
+194
New +$6.31K ﹤0.01% 854
2022
Q2
Sell
-39
Closed -$1K 1703
2022
Q1
$1K Buy
39
+19
+95% +$582 ﹤0.01% 1427
2021
Q4
$1K Buy
+20
New +$607 ﹤0.01% 1307
2019
Q1
Sell
-35
Closed -$1.16K 982
2018
Q4
$1.16K Hold
35
﹤0.01% 894
2018
Q3
$1.76K Hold
35
﹤0.01% 850
2018
Q2
$2.1K Hold
35
﹤0.01% 868
2018
Q1
$1.6K Buy
+35
New +$1.46K ﹤0.01% 868

Other funds holding SUPN

MassMutual Private Wealth & Trust's SUPN Position: Q2 2026 in Review

MassMutual Private Wealth & Trust held its Supernus Pharmaceuticals (SUPN) position steady in Q2 2026 at 292 shares worth $13.6K. The position accounts for ﹤0.01% of the portfolio, ranked #1265.

MassMutual Private Wealth & Trust first reported a position in SUPN in Q1 2018 and has held it in 22 quarters since. The position peaked at $16.5K in Q4 2025. 27 funds tracked by Wall St. Rank hold SUPN as of Q2 2026.

  • MassMutual Private Wealth & Trust held 292 shares of Supernus Pharmaceuticals worth $13.6K as of Q2 2026.
  • MassMutual Private Wealth & Trust left its Supernus Pharmaceuticals share count unchanged in Q2 2026.
  • Supernus Pharmaceuticals made up ﹤0.01% of MassMutual Private Wealth & Trust's portfolio in Q2 2026, its #1265 holding.
  • MassMutual Private Wealth & Trust first reported a position in Supernus Pharmaceuticals in Q1 2018 and has held it in 22 quarters since.
  • MassMutual Private Wealth & Trust's Supernus Pharmaceuticals position peaked at $16.5K in Q4 2025.
  • 27 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q2 2026.

Based on MassMutual Private Wealth & Trust's 13F filing for Q2 2026, filed 2 Jul 2026.